<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">Malaria</z:e> and Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> are cofactors in the pathogenesis of endemic Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (eBL) </plain></SENT>
<SENT sid="1" pm="."><plain>The mechanisms by which these pathogens predispose to eBL are not known </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Healthy Kenyan children with divergent <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> exposure were measured for responses to EBV latent and lytic antigens by interferon (IFN)- gamma enzyme-linked immunospot (ELISPOT) assay and interleukin (IL)-10 ELISA </plain></SENT>
<SENT sid="3" pm="."><plain>Phytohemagglutinin (PHA), purified protein derivative (<z:chebi fb="48" ids="51403,53543">PPD</z:chebi>), and T cell <z:chebi fb="0" ids="53000">epitope</z:chebi> <z:chebi fb="7" ids="16670">peptides</z:chebi> derived from merozoite surface protein (MSP)-1, a <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> blood-stage antigen, were also evaluated </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Children 5-9 years old living in an area holoendemic for <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> had significantly fewer EBV-specific IFN- gamma responses than did children of the same age living in an area with unstable <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> transmission </plain></SENT>
<SENT sid="5" pm="."><plain>This effect was not observed for children &lt;5 years old or those &gt;9 years old </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, IFN- gamma responses to PHA, <z:chebi fb="48" ids="51403,53543">PPD</z:chebi>, and Plasmodium falciparum MSP-1 peptides did not significantly differ by age </plain></SENT>
<SENT sid="7" pm="."><plain>IL-10 responses to EBV lytic antigens, <z:chebi fb="48" ids="51403,53543">PPD</z:chebi>, and PHA correlated inversely with <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> exposure regardless of age </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Children living in <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e>-holoendemic areas have diminished EBV-specific T cell immunosurveillance between the ages of 5 and 9 years, which coincides with the peak age incidence of eBL </plain></SENT>
</text></document>